HealthQuill Pharma
US-based biotechnology company Viking Therapeutics Inc., reported ā€œpositiveā€ results from its early-stage weight-loss oral drug and the pill showed mild to moderate side effects.
Drugs Health Pharma

Viking Therapeuticsā€™ weight-loss drug shows ā€˜positiveā€™ results in early trials

US-based biotechnology company Viking Therapeutics Inc., reported ā€œpositiveā€ results from its early-stage weight-loss oral drug and the pill showed mild to moderate side.

Read More
The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to treat pulmonary arterial hypertension.
Drugs Health Pharma

US regulator clears Merckā€™s lung therapy after ā€˜significantā€™ results

Ā HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to.

Read More
The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to ā€œunreasonable and substantial riskā€ of illness or injury.
Drugs Medical Pharma

FDA attempts a second time to ban electrical stimulation devices

HQ Team March 26, 2024: The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to ā€œunreasonable and.

Read More
A trip through any of the Kerala villages would reveal many palatial mansions, some of them with one or two elderly inhabitants and many locked up forever.Ā 
Drugs Health Opinion Pharma

Opinion: Empty Nest syndrome grips elderly in southern Indian state

By Aparna S March 26, 2024: With a high literacy rate, the migration rates in Indiaā€™s southern state of Kerala have always been.

Read More
Novo Nordisk, one of the worldā€™s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises in heart diseases, for up to 1.03 billion euros ($1.1 billion).
Drugs Health Pharma

Novo to buy Cardior for $1.1b to expand cardiovascular segment

HQ Team March 25, 2024: Novo Nordisk, one of the worldā€™s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises.

Read More
AstraZenecaā€™s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.
Drugs Medical Pharma

UK researchers get $2.1 million to develop lung cancer vaccine

HQ Team March 23, 2024: Researchers in the UK have won a grant of $2.14 million (ā‚¬1.98 million) from the Cancer Research UK.

Read More
Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified pig, according to a statement from Massachusetts General Hospital.
Drugs Health Pharma

First genetically edited pig kidney gets transplanted into a human

HQ Team March 21, 2024: Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified.

Read More
An abnormal protein called phosphorylated Ī±-synuclein present in the nerve fibres in the skin ā€” the pathological hallmark of Parkinsonā€™s disease ā€” can be detected with high accuracy by a simple biopsy test, researchers say.
Drugs Health Pharma

Simple skin biopsy test can detect Parkinsonā€™s disease: Harvard study

HQ Team March 21, 2024: An abnormal protein called phosphorylated Ī±-synuclein present in the nerve fibres in the skin ā€” the pathological hallmark.

Read More
A panel consisting of Nobel laureates, former presidents and prime ministers has urged global negotiators of WHO member states to redouble their efforts to reach a consensus on the Pandemic Accord.
Drugs Health Pharma

Negotiators must close Pandemic Accord talks fast: Global panel

HQ Team March 21, 2024: A panel consisting of Nobel laureates, former presidents and prime ministers have urged global negotiators of WHO member.

Read More
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Drugs Health Pharma

Bristol Myers says liver cancer therapy trial improves overall survival rate

HQ Team March 20, 2024: Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival.

Read More